Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.

Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.

Item
http://www.wikidata.org/entity/Q30450923
Olmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney diseaseEpidemiology and outcomes of acute kidney injury in elderly chinese patients: a subgroup analysis from the EACH study.Angiotensin II type 1 receptor antagonists in the treatment of hypertension in elderly patients: focus on patient outcomes.Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort StudyNeuro-hormonal effects of physical activity in the elderly.Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.OLDER PEOPLE WITH CHRONIC KIDNEY DISEASE: DEFINITION, AND INFLUENCE OF BIOMARKERS AND MEDICATIONS UPON CARDIOVASCULAR AND RENAL OUTCOMES.Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3.Antihypertensive efficacy and safety of the angiotensin receptor blocker azilsartan in elderly patients with hypertension.Angiotensin II receptor blocker prevents upper gastrointestinal bleeding in hypertensive patients with chronic kidney disease not on dialysis.Antihypertensive efficacy of olmesartan medoxomil and ramipril in elderly patients with mild to moderate hypertension grouped according to renal function status : a retrospective analysis.Treatment of isolated systolic hypertension in the elderly.Renin-angiotensin-aldosterone system activation in long-standing type 1 diabetes.Effect of age on the pharmacokinetics of fimasartan (BR-A-657).
P2860

Renin-angiotensin-aldosterone system blockade effects on the kidney in the elderly: benefits and limitations.

Item
http://www.wikidata.org/entity/Q30450923
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@ast
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@en
type
label
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@ast
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@en
prefLabel
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@ast
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Renin-angiotensin-aldosterone ...... rly: benefits and limitations.
@en
P2093
P304
P31
P356
P433
P478
P577
P698